137 related articles for article (PubMed ID: 27391930)
41. Antiproliferative and apoptotic effects of a specific anti-insulin-like growth factor I receptor single chain antibody on breast cancer cells.
Motallebnezhad M; Younesi V; Aghebati-Maleki L; Nickho H; Safarzadeh E; Ahmadi M; Movassaghpour AA; Hosseini A; Yousefi M
Tumour Biol; 2016 Nov; 37(11):14841-14850. PubMed ID: 27639384
[TBL] [Abstract][Full Text] [Related]
42. Engineering of stable bispecific antibodies targeting IL-17A and IL-23.
Mabry R; Lewis KE; Moore M; McKernan PA; Bukowski TR; Bontadelli K; Brender T; Okada S; Lum K; West J; Kuijper JL; Ardourel D; Franke S; Lockwood L; Vu T; Frank A; Appleby MW; Wolf A; Reardon B; Hamacher NB; Stevens B; Lewis P; Lewis KB; Gilbertson DG; Lantry M; Julien SH; Ostrander C; Chan C; Byrnes-Blake K; Brody J; Presnell S; Meengs B; Levin SD; Snavely M
Protein Eng Des Sel; 2010 Mar; 23(3):115-27. PubMed ID: 20022918
[TBL] [Abstract][Full Text] [Related]
43. Biological activity in vitro of anti-epidermal growth factor receptor monoclonal antibodies with different affinities.
Diaz Miqueli A; Blanco R; Garcia B; Badia T; Batista AE; Alonso R; Montero E
Hybridoma (Larchmt); 2007 Dec; 26(6):423-31. PubMed ID: 18158788
[TBL] [Abstract][Full Text] [Related]
44. Cloning, expression and efficient refolding of carbohydrate-peptide mimicry recognizing single chain antibody 2D10.
Tapryal S; Krishnan L; Batra JK; Kaur KJ; Salunke DM
Protein Expr Purif; 2010 Aug; 72(2):162-8. PubMed ID: 20363331
[TBL] [Abstract][Full Text] [Related]
45. Structural and functional characterization of the single-chain Fv fragment from a unique HCV E1E2-specific monoclonal antibody.
Fallecker C; Tarbouriech N; Habib M; Petit MA; Drouet E
FEBS Lett; 2013 Oct; 587(20):3335-40. PubMed ID: 24021643
[TBL] [Abstract][Full Text] [Related]
46. A novel fully-human cytolytic fusion protein based on granzyme B shows in vitro cytotoxicity and ex vivo binding to solid tumors overexpressing the epidermal growth factor receptor.
Niesen J; Hehmann-Titt G; Woitok M; Fendel R; Barth S; Fischer R; Stein C
Cancer Lett; 2016 May; 374(2):229-40. PubMed ID: 26912070
[TBL] [Abstract][Full Text] [Related]
47. Selection, affinity maturation, and characterization of a human scFv antibody against CEA protein.
Pavoni E; Flego M; Dupuis ML; Barca S; Petronzelli F; Anastasi AM; D'Alessio V; Pelliccia A; Vaccaro P; Monteriù G; Ascione A; De Santis R; Felici F; Cianfriglia M; Minenkova O
BMC Cancer; 2006 Feb; 6():41. PubMed ID: 16504122
[TBL] [Abstract][Full Text] [Related]
48. SNAP-tagging the retrograde route.
Johannes L; Shafaq-Zadah M
Methods Cell Biol; 2013; 118():139-55. PubMed ID: 24295305
[TBL] [Abstract][Full Text] [Related]
49. Targeting the extracellular domain of fibroblast growth factor receptor 3 with human single-chain Fv antibodies inhibits bladder carcinoma cell line proliferation.
Martínez-Torrecuadrada J; Cifuentes G; López-Serra P; Saenz P; Martínez A; Casal JI
Clin Cancer Res; 2005 Sep; 11(17):6280-90. PubMed ID: 16144932
[TBL] [Abstract][Full Text] [Related]
50. Genetic fusion of single-chain variable fragments to partial spider silk improves target detection in micro- and nanoarrays.
Thatikonda N; Delfani P; Jansson R; Petersson L; Lindberg D; Wingren C; Hedhammar M
Biotechnol J; 2016 Mar; 11(3):437-48. PubMed ID: 26470853
[TBL] [Abstract][Full Text] [Related]
51. Generation and characterization of a target-selectively activated antibody against epidermal growth factor receptor with enhanced anti-tumor potency.
Yang Y; Guo Q; Xia M; Li Y; Peng X; Liu T; Tong X; Xu J; Guo H; Qian W; Hou S; Dai J; Wang H; Liu R; Guo Y
MAbs; 2015; 7(2):440-50. PubMed ID: 25679409
[TBL] [Abstract][Full Text] [Related]
52. Synthesis and purification of a toxin-linked conjugate targeting epidermal growth factor receptor in Escherichia coli.
Ma C; Li Y; Li Z; Huang H; Xu K; Xu H; Bai J; Li X; Zhao G
Protein Expr Purif; 2012 May; 83(1):1-7. PubMed ID: 22381467
[TBL] [Abstract][Full Text] [Related]
53. Human Antibody Fusion Proteins/Antibody Drug Conjugates in Breast and Ovarian Cancer.
Padayachee ER; Biteghe FAN; Malindi Z; Bauerschlag D; Barth S
Transfus Med Hemother; 2017 Sep; 44(5):303-310. PubMed ID: 29070975
[TBL] [Abstract][Full Text] [Related]
54. Generation and functional characterization of intracellular antibodies interacting with the kinase domain of human EGF receptor.
Hyland S; Beerli RR; Barbas CF; Hynes NE; Wels W
Oncogene; 2003 Mar; 22(10):1557-67. PubMed ID: 12629519
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of two novel tag-based labelling technologies for site-specific modification of proteins.
Tirat A; Freuler F; Stettler T; Mayr LM; Leder L
Int J Biol Macromol; 2006 Aug; 39(1-3):66-76. PubMed ID: 16503347
[TBL] [Abstract][Full Text] [Related]
56. Prokaryotic expression and refolding of EGFR extracellular domain and generation of phage display human scFv against EGFR.
Zhou Y; Zhang J; Jin H; Chen Z; Wu Q; Li W; Yue M; Luo C; Wang M
Biomed Pharmacother; 2013 Oct; 67(8):737-43. PubMed ID: 23639232
[TBL] [Abstract][Full Text] [Related]
57. Generation of an intrabody-based reagent suitable for imaging endogenous proliferating cell nuclear antigen in living cancer cells.
Freund G; Desplancq D; Stoessel A; Weinsanto R; Sibler AP; Robin G; Martineau P; Didier P; Wagner J; Weiss E
J Mol Recognit; 2014 Sep; 27(9):549-58. PubMed ID: 25042709
[TBL] [Abstract][Full Text] [Related]
58. Targeted delivery of dendritic polyglycerol-doxorubicin conjugates by scFv-SNAP fusion protein suppresses EGFR+ cancer cell growth.
Hussain AF; Krüger HR; Kampmeier F; Weissbach T; Licha K; Kratz F; Haag R; Calderón M; Barth S
Biomacromolecules; 2013 Aug; 14(8):2510-20. PubMed ID: 23782069
[TBL] [Abstract][Full Text] [Related]
59. A bispecific transmembrane antibody simultaneously targeting intra- and extracellular epitopes of the epidermal growth factor receptor inhibits receptor activation and tumor cell growth.
Müller N; Hartmann C; Genssler S; Koch J; Kinner A; Grez M; Wels WS
Int J Cancer; 2014 Jun; 134(11):2547-59. PubMed ID: 24243620
[TBL] [Abstract][Full Text] [Related]
60. Screening and evaluation of human single-chain fragment variable antibody against hepatitis B virus surface antigen.
Zhang JL; Gou JJ; Zhang ZY; Jing YX; Zhang L; Guo R; Yan P; Cheng NL; Niu B; Xie J
Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):237-41. PubMed ID: 16698583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
